Back to companies
Travere Therapeutics, Inc.
TVTXUSNASDAQPharmaceuticals & HealthcareTravere Therapeutics, Inc.
Revenue
$490.7mn
YoY +110.5%
Operating income
-$62.8mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API